PUBLISHING THE MARCH 26, 2025, FDA LETTER ENDORSING VAT-EXEMPT PRODUCT LIST UPDATES UNDER THE TRAIN AND CREATE LAWS

Introduction

REVENUE MEMORANDUM CIRCULAR (RMC) NO. 059-2025

Publishes in full the letter (Annex A: RMC 59-2025 Annex A.pdf ) dated March 26, 2025 issued by the Food and Drug Administration (FDA) and endorsed by the Department of Health (DOH), which provides an updated list of VAT-exempt pharmaceutical products and medical devices pursuant to the TRAIN Law (RA No. 10963) and the CREATE Act (RA No. 11534).